MiMedx Group Inc. received another noncompliance notice from the Nasdaq stock market for failing to file a periodic report.
The Marietta, Ga.-based company is yet to file its quarterly earnings report for the three months ended March 31.
MiMedx previously received a Nasdaq notice for failing to file its annual report for the year ended Dec. 31, 2017. The company, which develops regenerative biomaterial products and bioimplants, has submitted to Nasdaq a plan to regain compliance.
The Nasdaq notice has no immediate effect on the listing of the company's common stock.